Bacterial enzymes involved in metabolic pathways

Bacterial enzymes involved in metabolic pathways comprise a vast array of proteins that catalyze the chemical reactions necessary for bacterial life, including the synthesis of the cell wall, nucleic acids, and essential metabolites. These enzymes are among the most successful therapeutic targets in medicine, allowing for the selective inhibition of bacterial growth with minimal impact on human host cells due to evolutionary divergence in metabolic strategies (StatPearls, 2024). Notable examples include dihydropteroate synthase and dihydrofolate reductase in the folate biosynthesis pathway, which are targeted by sulfonamides and trimethoprim, respectively (PubMed, 2023). Additionally, enzymes like DNA gyrase and RNA polymerase are critical for genetic processing and are targeted by fluoroquinolones and rifamycins (NIH, 2023). However, because this target description refers to a broad functional category rather than a specific protein, it encompasses diverse families such as transferases, ligases, and oxidoreductases (UniProt, 2024). The continued study of these metabolic pathways is vital for developing next-generation antibiotics to overcome the rising challenge of antimicrobial resistance (Nature, 2022).

Other names

Bacterial metabolic enzymesAntibacterial targetsProkaryotic metabolic enzymesBacterial metabolism proteins

Inhibition of essential biochemical reactions required for bacterial cell wall integrity, DNA replication, or nutrient synthesis, leading to bacteriostatic or bactericidal effects.